Brazilian researchers, in partnership with French institutions, have developed a tool that can predict how patients will respond to natalizumab, one of the most commonly used drugs for treating ...

While squamous cell carcinoma diagnosis is often easy, the challenge lies in the preoperative assessment — determining how aggressively the tumour is growing to plan and prioritise surgery ...